Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomized controlled trial - Reid, D M; Devogelaer, J P; Saag, K (Lancet, 2009)
et al.